"People put most of it back on in the first three to six months," he says
doi: 10.1038/nrd.2017.162 33 KhomichO
Clinics offering FDA-approved brands or oral options are better aligned with that preference
The earlier SUSTAIN dose-finding studies for diabetes (Nauck et al., Diabetes Care, 2016) tested multiple dose levels including 0.05 mg, 0.1 mg, 0.2 mg, 0.3 mg, and 0.4 mg daily (note: daily, not weekly) of oral semaglutide and found dose-dependent reductions in HbA1c and body weight at every dose tested
Studies Investigating IGF-1 and Related Analogs in Cellular and Metabolic Research Models
Most, if not all of your write-offs, will be deductions